Citations with the tag: RECTUM -- Cancer -- Treatment

Results 1 - 50

  • A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation...
    Gelber, Richard D.; Goldhirsch, Aron // JNCI: Journal of the National Cancer Institute; 08/07/96, Vol. 88 Issue 15, p1039 

    Focuses on the improvement of survival rates for rectal cancer patients receiving adjuvant radiation therapy and chemotherapy following surgery. Assessment of toxic effects of cancer treatment; Analysis standards used to determine treatment success.

  • Preoperative Chemoradiation and Coloanal J Pouch Reconstruction for Low Rectal Cancer.
    Chaudhry, Vivek; Nittala, Murali; Prasad, Madhava L. // American Surgeon; Apr2000, Vol. 66 Issue 4, p387 

    Our objective was to determine clinical outcomes of treatment of low rectal adenocarcinoma with neoadjuvant chemoradiation, rectal excision, and coloanal J pouch reconstruction. A retrospective review of 69 patients with stage B2 or higher lesions was performed. Preoperative chemoradiation was...

  • Calcium supplementation and rectal mucosal proliferation: A randomized controlled trial.
    Baron, John A.; Tosteson, Tor D. // JNCI: Journal of the National Cancer Institute; 9/6/95, Vol. 87 Issue 17, p1303 

    Examines the effect of calcium supplementation on rectal mucosal proliferation in humans. Absence of effect of calcium supplementation on rectal mucosal proliferation; Insufficiency of evidence for the anticarcinogenic effect of calcium.

  • Colorectal carcinoma in patients 30 years of age and younger.
    McGahren III, Eugene D.; Mills, Stacey E. // American Surgeon; Jan1995, Vol. 61 Issue 1, p78 

    Studies the treatment of colorectal cancer in patients aged 30 years or younger at the University of Virginia Health Sciences Center. Physical findings; Onset of symptoms; Precancerous conditions; Surgical interventions.

  • Advanced rectal cancer.
    Williams, J. Alexander // BMJ: British Medical Journal (International Edition); 2/3/90, Vol. 300 Issue 6720, p276 

    Focuses on the conservative and palliative management of advanced rectal cancer. Use of local resection by the transanal or transphincteric route; Clinical trials on chemotherapy in rectal cancer; Efficacy of diathermy resection in a fluid medium.

  • Long-term survival after "liver first" approach for locally advanced rectal cancer and synchronous liver metastases.
    Radunz, Sonia; Heuer, Matthias; Trarbach, Tanja; Mathe, Zoltan; Baba, Hideo A.; Paul, Andreas; Sotiropoulos, Georgios C. // International Journal of Colorectal Disease; Sep2011, Vol. 26 Issue 9, p1219 

    A letter to the editor is presented in response to an article concerning the treatment of advanced rectal cancer and synchronous colorectal liver metastases.

  • Differences found in rectal cancer treatment between European countries.
    Radunz, Sonia; Heuer, Matthias; Trarbach, Tanja; Mathe, Zoltan; Baba, Hideo A.; Paul, Andreas; Sotiropoulos, Georgios C. // Hem/Onc Today; 10/25/2011, Vol. 12 Issue 20, p38 

    The article discusses the findings of a study by Colette van den Broek and colleagues which showed differences in the use of chemotherapy and radiotherapy for rectal cancer between European countries.

  • Commentary: Rectal Cancer--An Evolution of Treatment.
    Czito, Brian G.; Willett, Christopher G. // Oncologist; Nov2007, Vol. 12 Issue 11, p1319 

    The article focuses on the evolution of treatment of rectal cancer. It states that neoadjuvant chemoradiotherapy with total mesorectal excision has become a standard treatment for the locally advanced disease in the U.S. and Europe. It mentions that newer generation cytotoxic chemotherapeutics...

  • Optimising Treatment for Resectable Rectal Cancer: Is Preoperative Therapy Beneficial?
    Ngan, S.Y.K. // Drugs & Aging; 2001, Vol. 18 Issue 2, p79 

    Preoperative radiotherapy is becoming the standard of care for resectable locally advanced adenocarcinoma of the rectum. Its practice is no longer limited to a few specialised cancer centres. Adjuvant preoperative radiotherapy can reduce the risk of local recurrence by 50% compared with surgery...

  • Therapy changes "sharply" increase survival in rectal cancer.
    Ngan, S.Y.K. // PharmacoEconomics & Outcomes News; 3/20/2010, Issue 599, p8 

    The article discusses research by M. A. Elferink et al, published in the February 19, 2010 issue of the "European Journal of Cancer," which found that new forms of therapy, such as preoperative radiotherapy and chemotherapy, have greatly benefited those suffering from rectal cancer.

  • No long-term QOL benefit for CRT.
    Ngan, S.Y.K. // PharmacoEconomics & Outcomes News; 9/17/2011, Issue 637, p10 

    The article reports on research from Norway and Sweden which revealed that preoperative chemoradiotherapy (CRT) does not offer better long-term health-related quality of life (QOL) benefit in patients with primarily non-resectable rectal cancer, in comparison to radiotherapy alone.

  • Radiation therapy plus surgery extended OS in metastatic rectal cancer.
    Ngan, S.Y.K. // Hem/Onc Today; 1/10/2014, Vol. 15 Issue 1, p8 

    The article discusses the study that found longer survival in patients with primary rectal or rectosigmoid tumors, who were treated with pelvic radiation therapy and surgery compared to those treated with surgery alone, a treatment commonly used in patients with rectosigmoid tumors.

  • Local recurrence after rectal cancer treatment in Manitoba.
    Latosinsky, Steven; Turner, Donna // Canadian Journal of Surgery; Feb2009, Vol. 52 Issue 1, p45 

    Background: By optimizing surgical and/or radiotherapy treatment, local recurrence rates of resectable rectal cancers have been reported to be less than 10% in both clinical trials and in some population-based studies. We examined patterns of care and local recurrence rates for rectal cancers in...

  • Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer.
    Sun, D.-S.; Zhang, J.-D.; Li, L.; Y. Dai; Yu, J.-M.; Shao, Z.-Y. // British Journal of Radiology; Mar2012, Vol. 85 Issue 1011, p259 

    Objectives: To evaluate the efficacy and treatment-related toxicity of accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer (LRIRC). Methods: 72 patients with LRIRC who underwent the...

  • Evaluation of the learning curve in laparoscopic low anterior resection for rectal cancer.
    Kayano, Hajime; Okuda, Junji; Tanaka, Keitaro; Kondo, Keisaku; Tanigawa, Nobuhiko // Surgical Endoscopy; Sep2011, Vol. 25 Issue 9, p2972 

    Background: Laparoscopic low anterior resection for rectal cancer is considered to be more technically demanding than laparoscopic colectomy. This study aimed to analyze the learning curve for laparoscopic low anterior resection and to identify the factors that influence this learning curve....

  • Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Terzi, Cem; Canda, Aras Emure; Sagol, Ozgul; Atila, Koray; Sonmez, Devrim; Fuzun, Mehmet; Gorken, Ilknur B.; Oztop, Ilhan; Obuz, Funda // International Journal of Colorectal Disease; Jan2008, Vol. 23 Issue 1, p37 

    The ability to predict response to chemoradiotherapy before the treatment may allow protecting poorly responding patients from the side effects of neoadjuvant treatment. Several molecular markers have been proposed to radio and chemosensitivity of rectal cancer. In this study, from...

  • Lokale Diagnostik beim Rektumkarzinom.
    Ptok, H.; Gastinger, I.; Lippert, H. // Der Chirurg; May2012, Vol. 83 Issue 5, p448 

    Accurate pretherapeutic staging of rectal cancer is crucial for further therapeutic management and important for prognosis. The most accurate diagnostic tools in the assessment of T and N categories of rectal cancer are endorectal ultrasound (EUS) and magnetic resonance imaging (MRI)....

  • Pathologisches Staging und Response-Evaluation beim Rektumkarzinom.
    Wittekind, C.; Oberschmid, B // Der Chirurg; May2012, Vol. 83 Issue 5, p423 

    The application of so-called neoadjuvant therapy may induce changes in tumor tissues that have to be determined concerning the degree of severity (regression grading) and which also influence pathological staging. The extent of morphological changes (response) to be evaluated ranges from...

  • Valor pronóstico de la respuesta patológica a la radioquimioterapia preoperatoria en el cáncer de recto bajo localmente avanzado.
    BANNURA C., GUILLERMO; VARGAS N., CLAUDIO; BARRERA E., ALEJANDRO; MELO L., CARLOS; ILLANES F., FELIPE // Revista Chilena de Cirugia; Jun2013, Vol. 65 Issue 3, p236 

    Background: Preoperative chemo radiotherapy improves the prognosis of locally advanced low rectal cancer and induces a pathological response in the tumor, which may have prognostic value. Aim: To assess the results of rectal cancer treatment according to the degree of pathological response of...

  • Irinotecan.
    BANNURA C., GUILLERMO; VARGAS N., CLAUDIO; BARRERA E., ALEJANDRO; MELO L., CARLOS; ILLANES F., FELIPE // Reactions Weekly; 10/8/2011, Issue 1372, p21 

    The article describes the cases of two patients who developed febrile neutropenia following treatment with irinotecan for metastatic rectal cancer or sigmoid colon cancer.

  • A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance.
    Cafferty, Fay H.; Sasieni, Peter D.; Duffy, Stephen W. // Statistical Methods in Medical Research; Apr2009, Vol. 18 Issue 2, p163 

    There is evidence that the removal of adenomas, by endoscopy, from the large bowel can prevent the occurrence of colorectal cancer (CRC). However, the reduction in cancer incidence due to endoscopic surveillance is difficult to estimate. Studies of cohorts of adenoma patients typically rely on...

  • Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer.
    Ishihara, Soichiro; Watanabe, Toshiaki; Akahane, Takuya; Shimada, Ryu; Horiuchi, Atsushi; Shibuya, Hajima; Hayama, Tamuro; Yamada, Hideki; Nozawa, Keijiro; Igaki, Hiroshi; Matsuda, Keiji // International Journal of Colorectal Disease; Jul2011, Vol. 26 Issue 7, p911 

    Purpose: Adverse events may occur in patients receiving preoperative radiotherapy (PRT) for rectal cancers. The aim of this study is to clarify the clinical and pathological features of the patients with PRT-related adverse events, and the significance of the adverse events on the clinical...

  • Chemo Plus Radiation Before Surgery Boosts Tumor Response.
    Ishihara, Soichiro; Watanabe, Toshiaki; Akahane, Takuya; Shimada, Ryu; Horiuchi, Atsushi; Shibuya, Hajima; Hayama, Tamuro; Yamada, Hideki; Nozawa, Keijiro; Igaki, Hiroshi; Matsuda, Keiji // Radiology Today; Dec2011, Vol. 12 Issue 12, p31 

    The article focuses on a research which suggests that rectal cancer patient who utilize a new combination of the chemotherapy called capecitabine together with five weeks of radiation before surgery have an 88% chance of surviving the cancer. Radiation Oncologist Jean Pierre Gerard, highlights...

  • Quality Assurance Through Outcome Registration in Colorectal Cancer: An ECCO Initiative for Europe.
    van Gijn, Willem; van de Velde, Cornelis J. H. // European Journal of Clinical & Medical Oncology; 2011, Vol. 3 Issue 3, p1 

    In recent years there have been significant improvements in the outcome of rectal cancer treatment. Both new surgical techniques as well as effective neoadjuvant treatment regimens have contributed to these improvements. It is key to spread these advances toward every rectal cancer patient and...

  • Rectal Cancer Treatment and Survival -Comparison of Two 5 - Year Time Intervals.
    Krebs, Bojan; Ko�elj, Miran; Potrc, Stojan // Collegium Antropologicum; Jun2012, Vol. 36 Issue 2, p419 

    In last two decades there was a huge step forward concerning rectal cancer treatment. The aim of our study was comparison of two time intervals regarding the methods of treatment and results of radical rectal cancer surgery. 407 patients operated on for rectal cancer were included in study....

  • Complex rectal polyps: other treatment modalities required when offering a transanal endoscopic microsurgery service.
    Joyce, Myles R.; Eguare, Emmanuel; Kiernan, Fiona; Swan, Niall; Crotty, Paul; Neary, Paul; Keane, Frank B. // International Journal of Colorectal Disease; Sep2011, Vol. 26 Issue 9, p1177 

    Purpose: Complex rectal polyps may present a clinical challenge. The study aim was to assess different treatment modalities required in the management of patients referred for transanal endoscopic microsurgery. Methods: Patients referred with complex rectal polyps from 1998 to 2008 were entered...

  • Treatment outcomes in locally advanced colorectal carcinoma.
    Harish, K.; Narayanaswamy, Y. V.; Nirmala, S. // International Seminars in Surgical Oncology; 2004, Vol. 1, p8 

    Background: Locally advanced colorectal cancers form a distinct subgroup where contiguous organs could be involved without distant metastases and so may be amenable to curative surgical resection. It was our objective to report our experience in treating six such patients with operable locally...

  • Laparoscopic dissection of Denonvilliers' fascia and implications for total mesorectal excision for treatment of rectal cancer.
    Jin-Tung Liang; Hong-Shiee Lai; Kuo-Wei Cheng // Surgical Endoscopy; Mar2011, Vol. 25 Issue 3, p935 

    im: To inspect Denonvilliers' fascia and its relationship with neighboring oncologically and functionally important anatomic structures by laparoscopic approach. Methods: A total of 112 patients with middle or low rectal cancer were successfully treated by laparoscopic total mesorectal excision...

  • Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.
    Saelen, Marie; Flatmark, Kjersti; Folkvord, Sigurd; Wijn, Rik; Rasmussen, Heidi; Fodstad, �ystein; Ree, Anne // Angiogenesis; Dec2011, Vol. 14 Issue 4, p481 

    Tumor hypoxia is a common determinant of resistance to cytotoxic therapies and metastatic behavior. In rectal cancer patients receiving preoperative chemoradiotherapy, tyrosine kinase activities in tumors with poor and good treatment responses were found to differ. Given that tyrosine kinase...

  • Analysis of differentially expressed genes in human rectal carcinoma using suppression subtractive hybridization.
    Choi, So-young; Jang, Jun; Kim, Kyung // Clinical & Experimental Medicine; Dec2011, Vol. 11 Issue 4, p219 

    The existence and treatment of rectal cancer are important for the function of defecation and the quality of life. However, the precise mechanisms of rectal carcinogenesis remain unclear. To screen the overexpressed gene in rectal carcinoma, we performed suppressive subtractive hybridization...

  • SHORT CUTS.
    Tonks, Alison // BMJ: British Medical Journal (Overseas & Retired Doctors Edition; 3/14/2009, p624 

    The article presents research information obtained from articles published in various medical journals. One discusses the monoclonal antibody mepolizumab for treating asthma. Research that examined the routine use of proton pump inhibitors with clopidogrel in men treated for acute coronary...

  • The quandary of N0 disease after neoadjuvant therapy for rectal cancer.
    Madariaga, Maria Lucia L.; Berger, David L. // Journal of Gastrointestinal Oncology; Dec2012, Vol. 3 Issue 4, p299 

    The authors explore the prognosis for rectal cancer after neoadjuvant therapy. They note importnce of accurate pathological staging, which is highly dependent accurate assessment of lymph node status after total mesorectal excision. They cite an article features in the "Journal of...

  • Coronary Vasospasm Secondary to 5-Fluorouracil and Its Management: Case Report.
    Yildirim, Mustafa; Parlak, Cem; Sezer, Cem; Eryilmaz, Ramazan; Kaya, Cetin; Yildiz, Mustafa // Eurasian Journal of Medicine; Apr2011, Vol. 43 Issue 1, p54 

    Although rare, 5-fl uorouracil (5-FU) may lead to cardiotoxicity that presents with angina, elevated cardiac enzymes and electrocardiogram (ECG) changes. Coronary vasospasm related to 5-FU is a rare clinical entity in oncological practice and may be seen during both bolus and protracted...

  • Laparoscopic total mesorectal excision.
    Khanna, A. // Techniques in Coloproctology; Feb2013 Supplement, Vol. 17, p41 

    This article describes the operative technique that my colleagues and I apply to total mesorectal excision in patients with rectal cancer. A body of data support improvement of short-term outcomes over open resection. Although long-term data remain scarce, several ongoing trials may clarify this...

  • Robotic total mesorectal excision: operative technique and review of the literature.
    Kim, S.; Kwak, J. // Techniques in Coloproctology; Feb2013 Supplement, Vol. 17, p47 

    In recent years, an increasing number of reports have been published on robotic colorectal surgery; this modality has also garnered an increasing amount of attention from the colorectal society. Most of the interest has been in robotic total mesorectal excision (TME) for rectal cancer. The...

  • A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancer.
    Chitapanarux, I.; Chitapanarux, T.; Tharavichitkul, E.; Mayurasakorn, S.; Siriwittayakorn, P.; Yamada, S.; Lorvidhaya, V. // Biomedical Imaging & Intervention Journal; Oct-Dec2011, Vol. 7 Issue 4, p1 

    Objective: To evaluate the activity and safety of adding oxaliplatin to a standard chemoradiotherapy schema, including 5-fluorouracil (5-FU)/folinic acid (FA), in locally-advanced rectal cancer (LARC). Methods: Two cycles of oxaliplatin 130 mg/m2 plus FA 20 mg/m2 bolus for 5 days and 5-FU 350...

  • Prognostic Significance of the Lymph Node Ratio Regarding Recurrence and Survival in Rectal Cancer Patients Treated with Postoperative Chemoradiotherapy.
    Ji-Yoon Kim; Su-Mi Chung; Byung-Ock Choi; In-Kyu Lee; Chang-Hyeok An; Jong-Man Won; Mi-Ryeong Ryu // Gut & Liver; Apr2012, Vol. 6 Issue 2, p203 

    Background/Aims: To evaluate the prognostic impact of the lymph node ratio (LNR: the ratio of positive lymph nodes to the total number of lymph nodes examined) on disease recurrence and survival among rectal cancer patients who received curative surgery and postoperative chemoradiotherapy (CRT)....

  • Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer.
    Guerra, Luca; Niespolo, Rita; Pisa, Giuseppe; Ippolito, Davide; Ponti, Elena; Terrevazzi, Sara; Bovo, Giorgio; Sironi, Sandro; Gardani, Gianstefano; Messa, Cristina // Abdominal Imaging; Feb2011, Vol. 36 Issue 1, p38 

    Purpose: In order to analyze the changes of glucose metabolism by maximum standardized uptake value (SUVmax) of 18F-FDG PET/CT in patients with rectal cancer submitted to neoadjuvant radiochemotherapy (nRCT) and to correlate SUV changes with tumor regression grade (TRG). Methods and material:...

  • The use of laparoscopic surgery in the treatment of rectal cancer.
    Nicolae Rîşnoveanu; Augustin Cătălin Dima; Mircea Ciurea // Journal of Medicine & Life; Oct-Dec2010, Vol. 3 Issue 4, p402 

    The use of laparoscopic techniques in the treatment of rectal cancer was until recently regarded with skepticism, because it did not seem to fulfill the oncologic principles of open surgery. The first report of a rectal cancer case treated by using laparoscopy has been made approximately two...

  • Neo adjuvant chemo-radiotherapy and rectal cancer: Can India follow the West?
    Bansal, Vivek; Bhutani, Ritu; Doval, Dinesh; Kumar, Kapil; Pande, Pankaj; Kumar, Gaurav // Journal of Cancer Research & Therapeutics; Apr-Jun2012, Vol. 8 Issue 2, p209 

    Aims: The management of locally advanced rectal cancer has changed over the years with an emphasis on neoadjuvant chemo radiation therapy (CT-RT) followed by surgery. This study is undertaken to evaluate the efficacy of this treatment in our set of patients with a special focus on the outcome in...

  • TREATMENT OF RECTAL CARSINOID TUMOR BY ENDOSCOPIC SUBMUCOZAL RESECTION WITH A LIGATION DEVICE; A CASE REPORT.
    Demir, Mehmet; Gokturk, Huseyin Savas; Ozturk, Nevin Akcaer; Akkaya, Didem; Serin, Ender; Yilmaz, Ugur // Anatolian Journal of Clinical Investigation; 2010, Vol. 4 Issue 1, p44 

    Rectal carcinoid tumors smaller than 1 cm in diameter can be successfully treated by local excision, such as that using endoscop, because they infrequently metastasize. We report on a patient with rectal carcinoid tumour, who was treated successfully by endoscopic submucosal resection with a...

  • Bedeutung der Schnittbildverfahren für das Staging des Rektumkarzinoms.
    Schäfer, A.O.; Langer, M.; Baumann, T. // Der Chirurg; May2012, Vol. 83 Issue 5, p439 

    The ongoing diversification of treatment strategies for rectal cancer justifies the demand for highly specialized radiological imaging. Currently, numerous studies have underlined the ability of magnetic resonance imaging (MRI) to determine those parameters that are critical for therapeutic...

  • Residual Treatment Disparities After Oncology Referral for Rectal Cancer.
    Morris, Arden M.; Billingsley, Kevin G.; Hayanga, Awori J.; Matthews, Barbara; Baldwin, Laura-Mae; Birkmeyer, John D. // JNCI: Journal of the National Cancer Institute; 5/21/2008, Vol. 100 Issue 10, p738 

    Background Black patients with rectal cancer are considerably less likely than white patients to receive adjuvant therapy. We examined the hypothesis that the lower treatment rate for blacks is due to underreferral to medical and radiation oncologists. Methods We used 1992-1999 Surveillance,...

  • Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy.
    Seung-Gu Yeo; Min-Jeong Kim; Dae Yong Kim; Hee Jin Chang; Min Ju Kim; Ji Yeon Baek; Sun Young Kim; Tae Hyun Kim; Ji Won Park; Jae Hwan Oh // Radiation Oncology; 2013, Vol. 8 Issue 1, p1 

    Background: We investigated patterns of failure in patients with locally advanced rectal cancer (LARC) according to chemoradiotherapy (CRT) timing: pre-operative versus post-operative. Also, patterns of failure, particularly distant metastasis (DM), were analyzed according to tumor location...

  • Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older.
    Xin Cai; Hongbin Wu; Junjie Peng; Ji Zhu; Sanjun Cai; Gang Cai; Zhen Zhang // Radiation Oncology; 2013, Vol. 8 Issue 1, p1 

    Purpose: To assess the safety and outcomes of radiotherapy (RT) or chemoradiotherapy (CRT) in elderly patients (≥70) with rectal cancer. Methods: Elderly patients aged 70 and older with rectal cancer, who were treated with RT or CRT at a single institution, were retrospectively analyzed....

  • Phantom bladder pain.
    Park, Kyeong-Eon; Cheon, Kwang-Seong; Ok, Seong-Ho; Young Ju Jeong; Heon Keun Lee // Korean Journal of Anesthesiology; Oct2012, Vol. 63 Issue 4, p376 

    The article presents a case study of a 59-year-old male patient who was suffering from phantom bladder pain. It informs that the patient has undergone cystectomy and ureteroileal conduit due to rectal cancer nearly two years ago. It also mentions that saddle block was performed in the patient in...

  • Radiological imaging of rectal cancer.
    Lincender-Cvijetić, Lidija; Banjin-Čardžić, Maja; Vegar-Zubović, Sandra; Vrcić, Dunja // Acta Medica Academica; 2012, Vol. 41 Issue 2, p199 

    This article discusses the possibilities of diagnosing abdominal imaging in patients with rectal cancer, detecting lesions and assessing the stage of the lesions, in order to select the appropriate therapy. Before the introduction of imaging technologies, the diagnosis of colorectal pathology...

  • Perineal Rectosigmoidectomy for Rectal Prolapse Secondary to Rectal Cancer: A Case Report and Literature Review.
    Rawin Ingsirorat // Thai Journal of Surgery; Oct-Dec2012, Vol. 33 Issue 4, p142 

    We report here an 83-year-old woman presented with severe degree of rectal prolapse secondary to rectal cancer. She underwent perineal rectosigmoidectomy to correct rectal prolapse and also to treat rectal cancer. The result was good with free surgical margins and good sphincter function. This...

  • Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors.
    Moonkyoo Kong; Seong Eon Hong; Woo Suk Choi; Si-Young Kim; Jinhyun Choi // Cancer Research & Treatment; Jun2012, Vol. 44 Issue 2, p104 

    Purpose This study was designed to investigate the long-term oncologic outcomes for locally advanced rectal cancer patients after treatment with preoperative concurrent chemoradiotherapy followed by total mesorectal excision, and to identify prognostic factors that affect survival and pathologic...

  • Interval between Surgery and Radiation Therapy Is an Important Prognostic Factor in Treatment of Rectal Cancer.
    Jin Hee Kim; Sang Jun Byun; Seung Gyu Park; Young Kee Oh; Seong Kyu Baek // Cancer Research & Treatment; Sep2012, Vol. 44 Issue 3, p187 

    Purpose The purpose of this study is to evaluate survival and prognostic factors for rectal cancer, including interval between surgery and radiation therapy after surgery, radiation therapy, and chemotherapy. Materials and Methods We conducted a retrospective study of 153 patients with rectal...

Next 50 Results
Share

Other Topics